<DOC>
	<DOCNO>NCT01930656</DOCNO>
	<brief_summary>Background : The Taiwanese FRAX® ( Fracture Risk Assessment Tool ) calculator available online clinical use . Our Taiwanese Osteoporosis Clinical Treatment Guidelines suggest use American high risk cut-points consider treatment also suggest derive domestic cut-points cost-effective approach . Establishing cost-effective domestic cut-points policy suggestion couple mobile device wireless access would potentially increase usage FRAX® tool . Objectives : 1 ) Using literature review establish cost-effectiveness FRAX® cut-points . 2 ) To assess effectiveness mobile device assist FRAX® tool base osteoporosis diagnostic management model . 3 ) To provide FRAX® base reimbursement policy suggestion . Methods : 1 ) Investigators use FRAX® , cost-effectiveness key word search Pubmed international osteoporosis guideline well understand clinical application FRAX® country . Investigators also search epidemiological data osteoporosis , facture , quality life cost establish domestic cost-effeteness , translational approach FRAX® cut-points . 2 ) Three target population National Taiwan University Hospital ( NTUH ) select prospective study ( Group A : geriatric health exam clinic American cut-points , group B : orthopedic clinic translational approach cut-points group C : endocrine clinic cost-effectiveness cut-points , ) . A mobile device app application couple FRAX® tool use trained research assistant clinic wait period screen enroll high risk ( 75 clinic ) adult inform consent . Participants refer geriatric clinic systemic osteoporosis diagnose management . Percentage participant meet current NHI medication reimbursement regulation percentage self-pay medication calculate . Analysis stratify age gender . 3 ) The impact 3 different cut-points increment NHI reimbursement estimate . An osteoporosis expert group meet hold FRAX® base osteoporosis medication reimbursement modification NHI Department Health . Expected Outcomes : 1 ) To establish mobile device assist FRAX® base osteoporosis screen management model . 2 ) Base study result expert consensus , investigator provide policy suggestion FRAX® base reimbursement modification .</brief_summary>
	<brief_title>Mobile Device Help FRAX® Screening</brief_title>
	<detailed_description>This observational study . The study outcomes might base clinical physician opnions provide policy suggestion FRAX® cut-point consider treatment .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>age 4090 screen high risk FRAX treat antiosteoporosis medication within last 312 month ( depend medication type )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>osteoporisis</keyword>
	<keyword>fracture</keyword>
	<keyword>risk</keyword>
	<keyword>cost effectiveness</keyword>
	<keyword>FRAX</keyword>
	<keyword>mobile device</keyword>
</DOC>